Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.63 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.63 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.63 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.63 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21122315 | 0.98 | GRIK1 (0.65) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL10804881 | 0.98 | GRIK1 (0.65) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL7717787 | 0.98 | GRIK1 (0.65) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL400264 | 0.98 | GRIK1 (0.65) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL28600794 | 0.96 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| Hydrochloric Acid SCHEMBL3633016 | 0.96 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL977390 | 0.93 | CA2 (0.68) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL14397105 | 0.93 | CA2 (0.68) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL4738680 | 0.93 | CA2 (0.68) | GRIK1GRIK2SLC1A2SLC1A1CA2 | |
| SCHEMBL21245498 | 0.87 | ACE2 (0.62) | GRIK1GRIK2SLC1A2SLC1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1476451-A1 | USE OF CERTAIN DILUENTS FOR MAKING BISPHOSPHONIC ACIDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-11-17 | — | — | EP | claimed |
| WO-2003097655-A1 | USE OF CERTAIN DILUENTS FOR MAKING BISPHOSPHONIC ACIDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2003-11-27 | — | — | WO | claimed |
| EP-0660717-B1 | AMINOSTEROIDS FOR OPHTHALMIC USE | INSITE VISION INC (US) | 1998-03-11 | — | — | EP | claimed |
| EP-0674528-A4 | CYCLODEXTRIN AND POLYMER BASED DRUG DELIVERY SYSTEM. | INSITE VISION INC (US) | 1996-06-26 | — | — | EP | claimed |
| EP-0682520-A1 | COMBINATION OF A CALCIUM CHANNEL BLOCKER AND AN ANTIOXYDANT FOR TREATING ISCHEMIC DISEASES | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-22 | — | — | EP | claimed |
| EP-0674528-A1 | CYCLODEXTRIN AND POLYMER BASED DRUG DELIVERY SYSTEM | INSITE VISION INCORPORATED (US) | 1995-10-04 | — | — | EP | claimed |
| CN-1103316-A | Cyclodextrin and polymer based drug delivery system | INSITE VISION INC (US) | 1995-06-07 | — | — | CN | claimed |
| US-5332582-A | Lightly crosslinked carboxy-containing polymers | INSITE VISION INCORPORATED (US) | 1994-07-26 | — | — | US | claimed |
| WO-1994012185-A1 | COMBINATION OF A CALCIUM CHANNEL BLOCKER AND AN ANTIOXYDANT FOR TREATING ISCHEMIC DISEASES | THE UPJOHN COMPANY (US) | 1994-06-09 | — | — | WO | claimed |
| WO-1994012217-A1 | CYCLODEXTRIN AND POLYMER BASED DRUG DELIVERY SYSTEM | INSITE VISION INCORPORATED (US) | 1994-06-09 | — | — | WO | claimed |
| US-4996318-A | Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke | THE UPJOHN COMPANY (US) | 1991-02-26 | — | — | US | claimed |
| EP-0358676-A1 | PHARMACEUTICALLY ACTIVE AMINES | THE UPJOHN COMPANY (US) | 1990-03-21 | — | — | EP | claimed |
| EP-0354920-A1 | AMINO-9,10-SECOSTEROIDS | THE UPJOHN COMPANY (US) | 1990-02-21 | — | — | EP | claimed |
| EP-0293078-A1 | Pharmaceutically active amines | THE UPJOHN COMPANY (US) | 1988-11-30 | — | — | EP | claimed |
| WO-1988008424-A1 | PHARMACEUTICALLY ACTIVE AMINES | THE UPJOHN COMPANY (US) | 1988-11-03 | — | — | WO | claimed |
| WO-1988007527-A1 | AMINO-9,10-SECOSTEROIDS | THE UPJOHN COMPANY (US) | 1988-10-06 | — | — | WO | claimed |
| EP-0263213-A1 | C20 Through C26 amino steroids | THE UPJOHN COMPANY (US) | 1988-04-13 | — | — | EP | claimed |
| WO-1987007895-A1 | ANDROSTANE-TYPE AND CORTICAL AMINOESTERS | THE UPJOHN COMPANY (US) | 1987-12-30 | — | — | WO | claimed |
| EP-0238545-A1 | C 20? THROUGH C 26? AMINO STEROIDS. | UPJOHN CO (US) | 1987-09-30 | — | — | EP | claimed |
| WO-1987001706-A2 | C20 THROUGH C26 AMINO STEROIDS | THE UPJOHN COMPANY (US) | 1987-03-26 | — | — | WO | claimed |